Compounds > tadalafil
Page last updated: 2024-09-02

tadalafil and Urination Disorders

tadalafil has been researched along with Urination Disorders in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elion-Mboussa, A; McVary, KT; Roehrborn, CG; Viktrup, L1
Brock, GB; Broderick, GA; Elion-Mboussa, A; Roehrborn, CG; Viktrup, L; Watts, SD1
de la Rosette, JJ1
Kaplan, SA1
Khazaeli, D; Moombeini, H; Salari Panah Firouzabadi, M; Taie, K1
Bergamasco, L; Gualà, L; Maselli, G; Pace, G; Silvestri, V; Vicentini, C1

Trials

3 trial(s) available for tadalafil and Urination Disorders

ArticleYear
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    The Journal of urology, 2008, Volume: 180, Issue:4

    Topics: Administration, Oral; Aged; Carbolines; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Multivariate Analysis; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Reference Values; Severity of Illness Index; Tadalafil; Treatment Outcome; Urination Disorders; Urodynamics

2008
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction.
    Urology, 2010, Volume: 75, Issue:6

    Topics: Aged; Carbolines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Phosphodiesterase Inhibitors; Probability; Prostatic Hyperplasia; Prostatism; Quality of Life; Reference Values; Risk Assessment; Severity of Illness Index; Tadalafil; Treatment Outcome; Urination Disorders; Urodynamics

2010
Tadalafil versus solifenacin for persistent storage symptoms after prostate surgery in patients with erectile dysfunction: a prospective randomized study.
    International journal of urology : official journal of the Japanese Urological Association, 2011, Volume: 18, Issue:7

    Topics: Aged; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Muscarinic Antagonists; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Surveys and Questionnaires; Tadalafil; Tetrahydroisoquinolines; Therapeutics; Urination Disorders; Urodynamics

2011

Other Studies

3 other study(ies) available for tadalafil and Urination Disorders

ArticleYear
Editorial comment.
    Urology, 2010, Volume: 75, Issue:6

    Topics: Carbolines; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Prostatism; Quality of Life; Risk Assessment; Tadalafil; Treatment Outcome; Urination Disorders

2010
Editorial comment.
    Urology, 2010, Volume: 75, Issue:6

    Topics: Carbolines; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Prostatism; Quality of Life; Tadalafil; Treatment Outcome; Urination Disorders

2010
Improvement of urodynamic indices by single dose oral tadalafil in men with supra sacral spinal cord injury.
    Urology journal, 2010,Fall, Volume: 7, Issue:4

    Topics: Carbolines; Humans; Male; Phosphodiesterase 5 Inhibitors; Pilot Projects; Spinal Cord Injuries; Tadalafil; Urinary Bladder; Urination Disorders; Urodynamics

2010